Al­ler­gan snatch­es Aus­tralian aes­thet­ics com­pa­ny Elasta­gen for $95M

Botox-mak­er Al­ler­gan $AGN has ac­quired Uni­ver­si­ty of Syd­ney spin-off Elasta­gen, which has a prod­uct to treat stretch marks and ac­ne, for $95 mil­lion.

Elasta­gen’s tech …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER